Tapestry Pharmaceuticals, Inc., together with its subsidiaries, develops therapies for the treatment of cancer. Its development stages therapeutic candidate products include TPI 287 IV, a Phase I product for prostate, nonsmall cell lung, and breast cancers; TPI 287 oral formulation, a preclinical development stage product for prostate, nonsmall cell lung, pancreatic, ovarian, breast, and colon cancers. The company’s development stages products also comprise Quassinoids and Linked Cytotoxics, preclinical development stage products for Cancers. Tapestry Pharmaceuticals was founded in 1991 and is based in Boulder, Colorado.
read more
QUOTE
As of 01:20PM EDT May 25, 2012
$
( )
Today's Open:
Today's Close:
| Today's High: |
|
Volume (thous): |
|
| Today's Low: |
|
Avg Vol (thous): |
|
| 52 Week High: |
|
Bid (size): |
|
| 52 Week Low: |
|
Ask (size): |
|
COMPANY INFO
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer:
Company Details:
| Symbol: |
TPPH |
| SIC: |
-
|
| State location: |
CO |
| Sector: |
- |
| State of Inc: |
DE |
| Employees: |
32 |
| Type: |
NASDAQ |
TAPESTRY PHARM (TPPH) MESSAGE BOARD
